SCHEMBL10076299

SCHEMBL10076299

CCc1cc(CC)cc(NC(=O)CN(C)C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
KMT2A Q03164 3/20 0.45
NPY5R Q15761 3/20 0.45
MEN1 O00255 2/20 0.45
KDM4E B2RXH2 2/20 0.45
POLB P06746 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
ALDH1A1 P00352 2/20 0.44
ATM Q13315 1/20 0.44
TAAR1 Q96RJ0 1/20 0.43
TNKS O95271 1/20 0.42
PARP1 P09874 1/20 0.42
PARP15 Q460N3 1/20 0.42
PARP14 Q460N5 1/20 0.42
PARP10 Q53GL7 1/20 0.42
PARP12 Q9H0J9 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
PARP2 Q9UGN5 1/20 0.42
PARP4 Q9UKK3 1/20 0.42
PARP3 Q9Y6F1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12655114 0.83 MAPT (0.62) MAPTKMT2ANPY5RMEN1POLB
SCHEMBL8251271 0.82 KMT2A (0.63) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL10076296 0.78 TERT (0.46) MAPTKMT2APOLBALDH1A1TAAR1
SCHEMBL14075745 0.75 MAPT (0.49) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL31574397 0.75 KMT2A (0.51) MAPTKMT2AMEN1KDM4EPOLB
SCHEMBL10076294 0.75 CYP1A1 (0.56) MAPTKMT2AKDM4EPOLBL3MBTL1
SCHEMBL31440566 0.75 MAPT (0.47) MAPTKMT2ANPY5RPOLBL3MBTL1
SCHEMBL14075740 0.75 LMNA (0.54) MAPTKMT2AMEN1POLBL3MBTL1
SCHEMBL10916539 0.74 MAPT (0.63) MAPTKMT2ANPY5RMEN1POLB
SCHEMBL12139523 0.74 ALDH1A1 (0.50) MAPTNPY5RKDM4EPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093231-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2012-01-10 US disclosed
US-8093231-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2012-01-10 US disclosed
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES TELIK, INC. 2008-02-14 US disclosed
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES TELIK, INC. 2008-02-14 US disclosed
US-7262182-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2007-08-28 US disclosed
US-7262182-B2 Sulfonylethyl phosphorodiamidates TELIK, INC. (US) 2007-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039429-A1 SULFONYLETHYL PHOSPHORODIAMIDATES MTAP, TYMP, PHOSPHO1 MAPT 3626/4885KMT2A 1619/4885NPY5R 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.